Literature DB >> 9653640

A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution.

G S Zubenko1, H B Hughes, J S Stiffler, M R Hurtt, B B Kaplan.   

Abstract

We completed a systematic survey of the human genome, conducted at an average resolution of 10 cM, for the identification of simple sequence tandem repeat polymorphisms (SSTRPs) that target new risk genes for Alzheimer disease (AD) by virtue of linkage disequilibrium. The efficiency of our association study was enhanced by genotyping pools of DNA from autopsy-confirmed cases with AD and matched controls. Allelic associations with AD were observed for 6 of the 391 SSTRPs in the CHLC Human Screening Set/Weber Version 6 (Research Genetics, Inc., Huntsville, AL): D1S518, D1S547, D10S1423, D12S1045, D19S178, and DXS1047. These allelic associations were replicated in an independent sample of autopsied AD cases and controls recruited from a geographically disparate site. The association of the large D19S178 alleles with AD appeared to arise from linkage disequilibrium with the APOE epsilon 4 allele, whose effect on increasing the risk of AD has been established. None of the remaining SSTRPs was in close proximity to loci previously reported to influence the risk of developing AD. Instead, they may identify five novel AD susceptibility loci.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9653640     DOI: 10.1006/geno.1998.5306

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  20 in total

1.  Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.

Authors:  Kalliopi Thanopoulou; Apostolia Fragkouli; Fotini Stylianopoulou; Spiros Georgopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-12       Impact factor: 11.205

2.  A genome-wide linkage analysis of dementia in the Amish.

Authors:  Daniel W Hahs; Jacob L McCauley; Amy E Crunk; Lynne L McFarland; Perry C Gaskell; Lan Jiang; Susan H Slifer; Jeffery M Vance; William K Scott; Kathleen A Welsh-Bohmer; Stephanie R Johnson; Charles E Jackson; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

3.  Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.

Authors:  Davis Ryman; Yuan Gao; Bruce T Lamb
Journal:  Neurobiol Aging       Date:  2007-04-02       Impact factor: 4.673

Review 4.  Tailoring of membrane proteins by alternative splicing of pre-mRNA.

Authors:  Kathleen F Mittendorf; Catherine L Deatherage; Melanie D Ohi; Charles R Sanders
Journal:  Biochemistry       Date:  2012-06-29       Impact factor: 3.162

Review 5.  Dancing in the dark? The status of late-onset Alzheimer's disease genetics.

Authors:  L Bertram; R E Tanzi
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

6.  Predicted gene sequence C10orf112 is transcribed, exhibits tissue-specific expression, and may correspond to AD7.

Authors:  George S Zubenko; Hugh B Hughes
Journal:  Genomics       Date:  2009-01-10       Impact factor: 5.736

7.  A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population.

Authors:  Fan Liu; Alejandro Arias-Vásquez; Kristel Sleegers; Yurii S Aulchenko; Manfred Kayser; Pascual Sanchez-Juan; Bing-Jian Feng; Aida M Bertoli-Avella; John van Swieten; Tatiana I Axenovich; Peter Heutink; Christine van Broeckhoven; Ben A Oostra; Cornelia M van Duijn
Journal:  Am J Hum Genet       Date:  2007-05-29       Impact factor: 11.025

Review 8.  Chasing genes in Alzheimer's and Parkinson's disease.

Authors:  Aida M Bertoli-Avella; Ben A Oostra; Peter Heutink
Journal:  Hum Genet       Date:  2004-03-04       Impact factor: 4.132

Review 9.  Genetics of Alzheimer's disease: a centennial review.

Authors:  Nilüfer Ertekin-Taner
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

10.  The genetics of Alzheimer's disease in Brazil: 10 years of analysis in a unique population.

Authors:  J R M Oliveira; A L Nishimura; R R Lemos; M Zatz
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.